• About us
• Contact

Advertisement

Organisation › Details

Health for Life Capital fund (HFL)

The Health for Life Capital investment vehicle is composed of a Luxembourg SICAR and a French FPCI (AIF fund). Seventure Partners acts as an Investment Advisor of the SICAR (Health for Life Management) General Partner, and as the Management Company of the FPCI. This Information is only intended for professional investors. Health for Life Capital™ bears a high risk. Investors could lose all of their investment. *

 

	Start	2014-01-20 closing, first
	Group	BPCE (Group)
	Industry	Health for Life Capital™ fund (HFL)
	Industry 2	microbiomics
	Person	de Crémoux, Isabelle (BPCE 201110– CEO of Seventure Partners)
	Person 2	Groyer, Sébastien (BPCE 201507 Parter at Seventure Partners)
	Region	Paris
	Country	France
	City	n. a.
		Address record changed: 2015-12-23
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

More documents for BPCE (Group)

• [1] ErVaccine Technologies S.A.. (1/5/23). "Press Release: ErVaccine Closes a €4.5 Million Financing Round and Prepares to Start Clinical Trial with Its First Therapeutic Cancer Vaccine in 2023". Lyon....
• [2] Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen....
• [3] Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen....
• [4] 77 Foods SAS (d/b/a La Vie Foods). (1/19/22). "Press Release: The Start-up La Vie Raises €25M and Sets Out to Conquer the World with Its New Generation of Plant-based Meat". Paris....
• [5] Abalos Therapeutics GmbH. (10/14/21). "Press Release: Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million". Düsseldorf....
• [6] LNC Therapeutics. (9/5/19). "Press Release: LNC Therapeutics Raises €6.2 Million for the Clinical Development of New Generation Drugs Based on the Gut Genome"....
• [7] Domain Therapeutics S.A.. (5/28/19). "Press Release: European Venture Capital Firm Seventure Partners Renews Its Support to Domain Therapeutics and Invests €3.5M ($3.9M) to Prepare the Next Growth Phase". Strasbourg....
• [8] Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris....
• [9] Seventure Partners. (3/1/19). "Press Release: Seventure Partners Life Sciences Corporate Update September 2018 – February 2019". Paris....
• [10] Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.